Letter to the editor: Antiretroviral drug resistance among treatment-naïve HIV-1-infected persons in Washington, D.C.

AIDS Patient Care and STDs

Volumn 22, Issue 6, 2008, Pages 445-448

  Boyd, Allison C ^a   Herzberg, Emily M ^a   Marshall, Mariah M ^a   Lamparello, Nicole A ^a   De Leon, Miguel A ^a   Porter, Allison ^a   Evans Jr , Charles H ^a   Doshi, Sarita ^b   Shahkolahi, Akbar ^b   Dekker, Debra ^b   Relf, Michael V ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b Whitman Walker Clinic   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; ANTIVIRAL RESISTANCE; BISEXUALITY; CLINICAL ARTICLE; CORRELATION FUNCTION; DNA SEQUENCE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENOTYPE; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MALE; PREVALENCE; PUBLIC HEALTH; SEXUAL ORIENTATION; UNITED STATES; VIRUS MUTATION; CLINICAL TRIAL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS GENOME;

ADULT; ANTI-RETROVIRAL AGENTS; DISTRICT OF COLUMBIA; DRUG RESISTANCE, VIRAL; FEMALE; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE;

EID: 47949133732     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0203     Document Type: Letter

References (11)

1. Novak RM, Chen L, MacArthur RD, et al. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naïve patients: Implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis 2005;40:468-474.
2. Susman E. Many HIV patients carry mutated drugresistant strains. Lancet 2002;359:49.
3. Gallant JE. Antiretroviral drug resistance and resistance testing. Top HIV Med 2005;13:138-142.
4. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. October 10, 2006, p6. http://aidsinfo.nih.gov/content files/AdultandAdolescentGL.pdf (last accessed November 29, 2007).
5. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-394.
6. Grant RM, Hecht F, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 2002;288:181-188.
7. Verbiest W, Brown S, Cohen C, et al. Prevalence of HIV-1 drug resistance in antiretroviral-naïve patients: A prospective study. AIDS 2001;15:647-650.
8. Barbour JD, Hecht FM, Wrin T, et al. Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS 2004;18:1683-1689.
9. Centers for Disease Control and Prevention. HIV/ AIDS Surveillance Report, 2005. Vol. 17. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006:[28]. http://cdc.gov/hiv/ topics/surveillance/resources/reports/ (Last accessed November 29, 2007).
10. Johnson VA, Brun-Vezinet F, Clotet B. Update of the drug resistance mutations in HIV-1:2007. Top HIV Med 2007;15:119-125.
11. D'Aquila RT, Schapiro JM, Brun-Vézinet F. Drug resistance mutations in HIV-1. Top HIV Med 2002;10:11-15.